The 2nd Driver of the Foundry Model and how it’s shaping the Molecular Diagnostics Industry

By |February 27th, 2018|Cost, Manufacturing, QA/QC|

Part Two- Leveraging Commonality The second driver that spawned the growth of the foundry model was the ability to Leverage Commonality. By the mid 1980’s, the techniques used to manufacture a wafer and eventually a semiconductor chip were largely co [...]

Celsee, Inc. Enters into Supply Agreement with Argonaut Manufacturing Services

By |February 15th, 2018|Business Development, News and Announcements, Press Release|

Carlsbad, CA, 02/14/18 – Argonaut Manufacturing Services, a contract manufacturing organization (CMO) serving the life science and molecular diagnostics markets, announced today it has entered into a supply agreement with Celsee, Inc. (“Celsee”), an [...]

Looking to Gain Value in Your Drug Product or IVD? Level-Up Your QC Program

By |February 8th, 2018|Cost, QA/QC, Tips and Tricks|

Many organizations view their QC program as a necessary evil- required by regulatory bodies and useful primarily to release product. However, defining and building a solid Quality Control program can unlock great value. Setting aside the need for fin [...]

Three Reasons why the Foundry Model will revolutionize manufacturing in the Molecular Diagnostics Industry

By |January 23rd, 2018|Cost, Manufacturing|

Part One - Keeping Pace in Innovation The foundry model is poised to fundamentally transform the biotechnology sector. As it revolutionized the semiconductor industry in the mid 1980’s, the foundry model brings to molecular diagnostic companies a met [...]